1 Market Overview of Smith-Magenis Syndrome Treatment 1.1 Smith-Magenis Syndrome Treatment Market Overview 1.1.1 Smith-Magenis Syndrome Treatment Product Scope 1.1.2 Smith-Magenis Syndrome Treatment Market Status and Outlook 1.2 Global Smith-Magenis Syndrome Treatment Market Size Overview by Region 2016 VS 2021VS 2027 1.3 Global Smith-Magenis Syndrome Treatment Market Size by Region (2016-2027) 1.4 Global Smith-Magenis Syndrome Treatment Historic Market Size by Region (2016-2021) 1.5 Global Smith-Magenis Syndrome Treatment Market Size Forecast by Region (2022-2027) 1.6 Key Regions, Smith-Magenis Syndrome Treatment Market Size (2016-2027) 1.6.1 North America Smith-Magenis Syndrome Treatment Market Size (2016-2027) 1.6.2 Europe Smith-Magenis Syndrome Treatment Market Size (2016-2027) 1.6.3 Asia-Pacific Smith-Magenis Syndrome Treatment Market Size (2016-2027) 1.6.4 Latin America Smith-Magenis Syndrome Treatment Market Size (2016-2027) 1.6.5 Middle East & Africa Smith-Magenis Syndrome Treatment Market Size (2016-2027) 2 Smith-Magenis Syndrome Treatment Market Overview by Type 2.1 Global Smith-Magenis Syndrome Treatment Market Size by Type: 2016 VS 2021 VS 2027 2.2 Global Smith-Magenis Syndrome Treatment Historic Market Size by Type (2016-2021) 2.3 Global Smith-Magenis Syndrome Treatment Forecasted Market Size by Type (2022-2027) 2.4 Medicine 2.5 Surgery 2.6 Other 3 Smith-Magenis Syndrome Treatment Market Overview by Application 3.1 Global Smith-Magenis Syndrome Treatment Market Size by Application: 2016 VS 2021 VS 2027 3.2 Global Smith-Magenis Syndrome Treatment Historic Market Size by Application (2016-2021) 3.3 Global Smith-Magenis Syndrome Treatment Forecasted Market Size by Application (2022-2027) 3.4 Hospital 3.5 Specialty Clinic 3.6 Homecare 3.7 Other 4 Smith-Magenis Syndrome Treatment Competition Analysis by Players 4.1 Global Smith-Magenis Syndrome Treatment Market Size by Players (2016-2021) 4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Smith-Magenis Syndrome Treatment as of 2020) 4.3 Date of Key Players Enter into Smith-Magenis Syndrome Treatment Market 4.4 Global Top Players Smith-Magenis Syndrome Treatment Headquarters and Area Served 4.5 Key Players Smith-Magenis Syndrome Treatment Product Solution and Service 4.6 Competitive Status 4.6.1 Smith-Magenis Syndrome Treatment Market Concentration Rate 4.6.2 Mergers & Acquisitions, Expansion Plans 5 Company (Top Players) Profiles and Key Data 5.1 Rhythm Pharmaceuticals 5.1.1 Rhythm Pharmaceuticals Profile 5.1.2 Rhythm Pharmaceuticals Main Business 5.1.3 Rhythm Pharmaceuticals Smith-Magenis Syndrome Treatment Products, Services and Solutions 5.1.4 Rhythm Pharmaceuticals Smith-Magenis Syndrome Treatment Revenue (US$ Million) & (2016-2021) 5.1.5 Rhythm Pharmaceuticals Recent Developments 5.2 Vanda Pharmaceuticals 5.2.1 Vanda Pharmaceuticals Profile 5.2.2 Vanda Pharmaceuticals Main Business 5.2.3 Vanda Pharmaceuticals Smith-Magenis Syndrome Treatment Products, Services and Solutions 5.2.4 Vanda Pharmaceuticals Smith-Magenis Syndrome Treatment Revenue (US$ Million) & (2016-2021) 5.2.5 Vanda Pharmaceuticals Recent Developments 5.3 Neurim Pharmaceuticals 5.5.1 Neurim Pharmaceuticals Profile 5.3.2 Neurim Pharmaceuticals Main Business 5.3.3 Neurim Pharmaceuticals Smith-Magenis Syndrome Treatment Products, Services and Solutions 5.3.4 Neurim Pharmaceuticals Smith-Magenis Syndrome Treatment Revenue (US$ Million) & (2016-2021) 5.3.5 Novartis Recent Developments 5.4 Novartis 5.4.1 Novartis Profile 5.4.2 Novartis Main Business 5.4.3 Novartis Smith-Magenis Syndrome Treatment Products, Services and Solutions 5.4.4 Novartis Smith-Magenis Syndrome Treatment Revenue (US$ Million) & (2016-2021) 5.4.5 Novartis Recent Developments 5.5 Takeda Pharmaceutical 5.5.1 Takeda Pharmaceutical Profile 5.5.2 Takeda Pharmaceutical Main Business 5.5.3 Takeda Pharmaceutical Smith-Magenis Syndrome Treatment Products, Services and Solutions 5.5.4 Takeda Pharmaceutical Smith-Magenis Syndrome Treatment Revenue (US$ Million) & (2016-2021) 5.5.5 Takeda Pharmaceutical Recent Developments 5.6 Sanofi 5.6.1 Sanofi Profile 5.6.2 Sanofi Main Business 5.6.3 Sanofi Smith-Magenis Syndrome Treatment Products, Services and Solutions 5.6.4 Sanofi Smith-Magenis Syndrome Treatment Revenue (US$ Million) & (2016-2021) 5.6.5 Sanofi Recent Developments 5.7 Johnson & Johnson 5.7.1 Johnson & Johnson Profile 5.7.2 Johnson & Johnson Main Business 5.7.3 Johnson & Johnson Smith-Magenis Syndrome Treatment Products, Services and Solutions 5.7.4 Johnson & Johnson Smith-Magenis Syndrome Treatment Revenue (US$ Million) & (2016-2021) 5.7.5 Johnson & Johnson Recent Developments 5.8 Eisai 5.8.1 Eisai Profile 5.8.2 Eisai Main Business 5.8.3 Eisai Smith-Magenis Syndrome Treatment Products, Services and Solutions 5.8.4 Eisai Smith-Magenis Syndrome Treatment Revenue (US$ Million) & (2016-2021) 5.8.5 Eisai Recent Developments 5.9 Teva Pharmaceutical Industries 5.9.1 Teva Pharmaceutical Industries Profile 5.9.2 Teva Pharmaceutical Industries Main Business 5.9.3 Teva Pharmaceutical Industries Smith-Magenis Syndrome Treatment Products, Services and Solutions 5.9.4 Teva Pharmaceutical Industries Smith-Magenis Syndrome Treatment Revenue (US$ Million) & (2016-2021) 5.9.5 Teva Pharmaceutical Industries Recent Developments 5.10 Boehringer Ingelheim International 5.10.1 Boehringer Ingelheim International Profile 5.10.2 Boehringer Ingelheim International Main Business 5.10.3 Boehringer Ingelheim International Smith-Magenis Syndrome Treatment Products, Services and Solutions 5.10.4 Boehringer Ingelheim International Smith-Magenis Syndrome Treatment Revenue (US$ Million) & (2016-2021) 5.10.5 Boehringer Ingelheim International Recent Developments 5.11 ALLERGAN 5.11.1 ALLERGAN Profile 5.11.2 ALLERGAN Main Business 5.11.3 ALLERGAN Smith-Magenis Syndrome Treatment Products, Services and Solutions 5.11.4 ALLERGAN Smith-Magenis Syndrome Treatment Revenue (US$ Million) & (2016-2021) 5.11.5 ALLERGAN Recent Developments 5.12 Roche Holding 5.12.1 Roche Holding Profile 5.12.2 Roche Holding Main Business 5.12.3 Roche Holding Smith-Magenis Syndrome Treatment Products, Services and Solutions 5.12.4 Roche Holding Smith-Magenis Syndrome Treatment Revenue (US$ Million) & (2016-2021) 5.12.5 Roche Holding Recent Developments 5.13 Purdue Pharma 5.13.1 Purdue Pharma Profile 5.13.2 Purdue Pharma Main Business 5.13.3 Purdue Pharma Smith-Magenis Syndrome Treatment Products, Services and Solutions 5.13.4 Purdue Pharma Smith-Magenis Syndrome Treatment Revenue (US$ Million) & (2016-2021) 5.13.5 Purdue Pharma Recent Developments 5.14 PhotoPharmics 5.14.1 PhotoPharmics Profile 5.14.2 PhotoPharmics Main Business 5.14.3 PhotoPharmics Smith-Magenis Syndrome Treatment Products, Services and Solutions 5.14.4 PhotoPharmics Smith-Magenis Syndrome Treatment Revenue (US$ Million) & (2016-2021) 5.14.5 PhotoPharmics Recent Developments 6 North America 6.1 North America Smith-Magenis Syndrome Treatment Market Size by Country (2016-2027) 6.2 United States 6.3 Canada 7 Europe 7.1 Europe Smith-Magenis Syndrome Treatment Market Size by Country (2016-2027) 7.2 Germany 7.3 France 7.4 U.K. 7.5 Italy 7.6 Russia 7.7 Nordic 7.8 Rest of Europe 8 Asia-Pacific 8.1 Asia-Pacific Smith-Magenis Syndrome Treatment Market Size by Region (2016-2027) 8.2 China 8.3 Japan 8.4 South Korea 8.5 Southeast Asia 8.6 India 8.7 Australia 8.8 Rest of Asia-Pacific 9 Latin America 9.1 Latin America Smith-Magenis Syndrome Treatment Market Size by Country (2016-2027) 9.2 Mexico 9.3 Brazil 9.4 Rest of Latin America 10 Middle East & Africa 10.1 Middle East & Africa Smith-Magenis Syndrome Treatment Market Size by Country (2016-2027) 10.2 Turkey 10.3 Saudi Arabia 10.4 UAE 10.5 Rest of Middle East & Africa 11 Smith-Magenis Syndrome Treatment Market Dynamics 11.1 Smith-Magenis Syndrome Treatment Industry Trends 11.2 Smith-Magenis Syndrome Treatment Market Drivers 11.3 Smith-Magenis Syndrome Treatment Market Challenges 11.4 Smith-Magenis Syndrome Treatment Market Restraints 12 Research Finding /Conclusion 13 Methodology and Data Source 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Disclaimer 13.4 Author List

List of Tables Table 1. Global Market Smith-Magenis Syndrome Treatment Market Size (US$ Million) Comparison by Region 2016 VS 2021 VS 2027 Table 2. Global Smith-Magenis Syndrome Treatment Market Size by Region (2016-2021) & (US$ Million) Table 3. Global Smith-Magenis Syndrome Treatment Market Size Share by Region (2016-2021) Table 4. Global Smith-Magenis Syndrome Treatment Forecasted Market Size by Region (2022-2027) & (US$ Million) Table 5. Global Smith-Magenis Syndrome Treatment Forecasted Market Size Share by Region (2022-2027) Table 6. Global Smith-Magenis Syndrome Treatment Market Size (US$ Million) by Type: 2016 VS 2021 VS 2027 Table 7. Global Smith-Magenis Syndrome Treatment Market Size by Type (2016-2021) & (US$ Million) Table 8. Global Smith-Magenis Syndrome Treatment Revenue Market Share by Type (2016-2021) Table 9. Global Smith-Magenis Syndrome Treatment Forecasted Market Size by Type (2022-2027) & (US$ Million) Table 10. Global Smith-Magenis Syndrome Treatment Revenue Market Share by Type (2022-2027) Table 11. Global Smith-Magenis Syndrome Treatment Market Size (US$ Million) by Application: 2016 VS 2021 VS 2027 Table 12. Global Smith-Magenis Syndrome Treatment Market Size by Application (2016-2021) & (US$ Million) Table 13. Global Smith-Magenis Syndrome Treatment Revenue Market Share by Application (2016-2021) Table 14. Global Smith-Magenis Syndrome Treatment Forecasted Market Size by Application (2022-2027) & (US$ Million) Table 15. Global Smith-Magenis Syndrome Treatment Revenue Market Share by Application (2022-2027) Table 16. Global Smith-Magenis Syndrome Treatment Revenue (US$ Million) by Players (2016-2021) Table 17. Global Smith-Magenis Syndrome Treatment Revenue Market Share by Players (2016-2021) Table 18. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Smith-Magenis Syndrome Treatment as of 2020) Table 19. Date of Key Manufacturers Enter into Smith-Magenis Syndrome Treatment Market Table 20. Global Smith-Magenis Syndrome Treatment Top Players Headquarters and Area Served Table 21. Smith-Magenis Syndrome Treatment Product Solution and Service Table 22. Global Smith-Magenis Syndrome Treatment Players Market Concentration Ratio (CR5 and HHI) Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Rhythm Pharmaceuticals Basic Information List Table 25. Rhythm Pharmaceuticals Description and Business Overview Table 26. Rhythm Pharmaceuticals Smith-Magenis Syndrome Treatment Products, Services and Solutions Table 27. Revenue (US$ Million) in Smith-Magenis Syndrome Treatment Business of Rhythm Pharmaceuticals (2016-2021) Table 28. Rhythm Pharmaceuticals Recent Developments Table 29. Vanda Pharmaceuticals Basic Information List Table 30. Vanda Pharmaceuticals Description and Business Overview Table 31. Vanda Pharmaceuticals Smith-Magenis Syndrome Treatment Products, Services and Solutions Table 32. Revenue (US$ Million) in Smith-Magenis Syndrome Treatment Business of Vanda Pharmaceuticals (2016-2021) Table 33. Vanda Pharmaceuticals Recent Developments Table 34. Neurim Pharmaceuticals Basic Information List Table 35. Neurim Pharmaceuticals Description and Business Overview Table 36. Neurim Pharmaceuticals Smith-Magenis Syndrome Treatment Products, Services and Solutions Table 37. Revenue (US$ Million) in Smith-Magenis Syndrome Treatment Business of Neurim Pharmaceuticals (2016-2021) Table 38. Neurim Pharmaceuticals Recent Developments Table 39. Novartis Basic Information List Table 40. Novartis Description and Business Overview Table 41. Novartis Smith-Magenis Syndrome Treatment Products, Services and Solutions Table 42. Revenue (US$ Million) in Smith-Magenis Syndrome Treatment Business of Novartis (2016-2021) Table 43. Novartis Recent Developments Table 44. Takeda Pharmaceutical Basic Information List Table 45. Takeda Pharmaceutical Description and Business Overview Table 46. Takeda Pharmaceutical Smith-Magenis Syndrome Treatment Products, Services and Solutions Table 47. Revenue (US$ Million) in Smith-Magenis Syndrome Treatment Business of Takeda Pharmaceutical (2016-2021) Table 48. Takeda Pharmaceutical Recent Developments Table 49. Sanofi Basic Information List Table 50. Sanofi Description and Business Overview Table 51. Sanofi Smith-Magenis Syndrome Treatment Products, Services and Solutions Table 52. Revenue (US$ Million) in Smith-Magenis Syndrome Treatment Business of Sanofi (2016-2021) Table 53. Sanofi Recent Developments Table 54. Johnson & Johnson Basic Information List Table 55. Johnson & Johnson Description and Business Overview Table 56. Johnson & Johnson Smith-Magenis Syndrome Treatment Products, Services and Solutions Table 57. Revenue (US$ Million) in Smith-Magenis Syndrome Treatment Business of Johnson & Johnson (2016-2021) Table 58. Johnson & Johnson Recent Developments Table 59. Eisai Basic Information List Table 60. Eisai Description and Business Overview Table 61. Eisai Smith-Magenis Syndrome Treatment Products, Services and Solutions Table 62. Revenue (US$ Million) in Smith-Magenis Syndrome Treatment Business of Eisai (2016-2021) Table 63. Eisai Recent Developments Table 64. Teva Pharmaceutical Industries Basic Information List Table 65. Teva Pharmaceutical Industries Description and Business Overview Table 66. Teva Pharmaceutical Industries Smith-Magenis Syndrome Treatment Products, Services and Solutions Table 67. Revenue (US$ Million) in Smith-Magenis Syndrome Treatment Business of Teva Pharmaceutical Industries (2016-2021) Table 68. Teva Pharmaceutical Industries Recent Developments Table 69. Boehringer Ingelheim International Basic Information List Table 70. Boehringer Ingelheim International Description and Business Overview Table 71. Boehringer Ingelheim International Smith-Magenis Syndrome Treatment Products, Services and Solutions Table 72. Revenue (US$ Million) in Smith-Magenis Syndrome Treatment Business of Boehringer Ingelheim International (2016-2021) Table 73. Boehringer Ingelheim International Recent Developments Table 74. ALLERGAN Basic Information List Table 75. ALLERGAN Description and Business Overview Table 76. ALLERGAN Smith-Magenis Syndrome Treatment Products, Services and Solutions Table 77. Revenue (US$ Million) in Smith-Magenis Syndrome Treatment Business of ALLERGAN (2016-2021) Table 78. ALLERGAN Recent Developments Table 79. Roche Holding Basic Information List Table 80. Roche Holding Description and Business Overview Table 81. Roche Holding Smith-Magenis Syndrome Treatment Products, Services and Solutions Table 82. Revenue (US$ Million) in Smith-Magenis Syndrome Treatment Business of Roche Holding (2016-2021) Table 83. Roche Holding Recent Developments Table 84. Purdue Pharma Basic Information List Table 85. Purdue Pharma Description and Business Overview Table 86. Purdue Pharma Smith-Magenis Syndrome Treatment Products, Services and Solutions Table 87. Revenue (US$ Million) in Smith-Magenis Syndrome Treatment Business of Purdue Pharma (2016-2021) Table 88. Purdue Pharma Recent Developments Table 89. PhotoPharmics Basic Information List Table 90. PhotoPharmics Description and Business Overview Table 91. PhotoPharmics Smith-Magenis Syndrome Treatment Products, Services and Solutions Table 92. Revenue (US$ Million) in Smith-Magenis Syndrome Treatment Business of PhotoPharmics (2016-2021) Table 93. PhotoPharmics Recent Developments Table 94. North America Smith-Magenis Syndrome Treatment Market Size by Country (2016-2021) & (US$ Million) Table 95. North America Smith-Magenis Syndrome Treatment Market Size by Country (2022-2027) & (US$ Million) Table 96. Europe Smith-Magenis Syndrome Treatment Market Size by Country (2016-2021) & (US$ Million) Table 97. Europe Smith-Magenis Syndrome Treatment Market Size by Country (2022-2027) & (US$ Million) Table 98. Asia-Pacific Smith-Magenis Syndrome Treatment Market Size by Region (2016-2021) & (US$ Million) Table 99. Asia-Pacific Smith-Magenis Syndrome Treatment Market Size by Region (2022-2027) & (US$ Million) Table 100. Asia-Pacific Smith-Magenis Syndrome Treatment Market Share by Region (2016-2021) Table 101. Asia-Pacific Smith-Magenis Syndrome Treatment Market Share by Region (2022-2027) Table 102. Latin America Smith-Magenis Syndrome Treatment Market Size by Country (2016-2021) & (US$ Million) Table 103. Latin America Smith-Magenis Syndrome Treatment Market Size by Country (2022-2027) & (US$ Million) Table 104. Middle East & Africa Smith-Magenis Syndrome Treatment Market Size by Players (2016-2021) & (US$ Million) Table 105. Middle East & Africa Smith-Magenis Syndrome Treatment Market Size by Country (2022-2027) & (US$ Million) Table 106. Smith-Magenis Syndrome Treatment Market Trends Table 107. Smith-Magenis Syndrome Treatment Market Drivers Table 108. Smith-Magenis Syndrome Treatment Market Challenges Table 109. Smith-Magenis Syndrome Treatment Market Restraints Table 110. Research Programs/Design for This Report Table 111. Key Data Information from Secondary Sources Table 112. Key Data Information from Primary Sources List of Figures Figure 1. Global Smith-Magenis Syndrome Treatment Market Size Year-over-Year 2016-2027 & (US$ Million) Figure 2. Global Smith-Magenis Syndrome Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 3. Global Smith-Magenis Syndrome Treatment Market Share by Regions: 2021 VS 2027 Figure 4. Global Smith-Magenis Syndrome Treatment Forecasted Market Size Share by Region (2022-2027) Figure 5. North America Smith-Magenis Syndrome Treatment Market Size (US$ Million) Growth Rate (2016-2027) Figure 6. Europe Smith-Magenis Syndrome Treatment Market Size (US$ Million) and Growth Rate (2016-2027) Figure 7. Asia-Pacific Smith-Magenis Syndrome Treatment Market Size (US$ Million) and Growth Rate (2016-2027) Figure 8. Latin America Smith-Magenis Syndrome Treatment Market Size (US$ Million) and Growth Rate (2016-2027) Figure 9. Middle East & Africa Smith-Magenis Syndrome Treatment Market Size (US$ Million) and Growth Rate (2016-2027) Figure 10. Global Smith-Magenis Syndrome Treatment Market Size Share by Type in 2021 & 2027 Figure 11. Medicine Market Size (US$ Million) YoY Growth (2016-2027) Figure 12. Surgery Market Size (US$ Million) YoY Growth (2016-2027) Figure 13. Other Market Size (US$ Million) YoY Growth (2016-2027) Figure 14. Global Smith-Magenis Syndrome Treatment Market Size Share by Application in 2021 & 2027 Figure 15. Hospital Market Size (US$ Million) YoY Growth (2016-2027) Figure 16. Specialty Clinic Market Size (US$ Million) YoY Growth (2016-2027) Figure 17. Homecare Market Size (US$ Million) YoY Growth (2016-2027) Figure 18. Other Market Size (US$ Million) YoY Growth (2016-2027) Figure 19. Smith-Magenis Syndrome Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 20. Global Top 5 and Top 10 Players Smith-Magenis Syndrome Treatment Market Share in 2020 Figure 21. North America Smith-Magenis Syndrome Treatment Market Share by Country (2016-2027) Figure 22. United States Smith-Magenis Syndrome Treatment Market Size (2016-2027) & (US$ Million) Figure 23. Canada Smith-Magenis Syndrome Treatment Market Size (2016-2027) & (US$ Million) Figure 24. Germany Smith-Magenis Syndrome Treatment Market Size (2016-2027) & (US$ Million) Figure 25. France Smith-Magenis Syndrome Treatment Market Size (2016-2027) & (US$ Million) Figure 26. U.K. Smith-Magenis Syndrome Treatment Market Size (2016-2027) & (US$ Million) Figure 27. Italy Smith-Magenis Syndrome Treatment Market Size (2016-2027) & (US$ Million) Figure 28. Russia Smith-Magenis Syndrome Treatment Market Size (2016-2027) & (US$ Million) Figure 29. Nordic Smith-Magenis Syndrome Treatment Market Size (2016-2027) & (US$ Million) Figure 30. Rest of Europe Smith-Magenis Syndrome Treatment Market Size (2016-2027) & (US$ Million) Figure 31. Asia-Pacific Smith-Magenis Syndrome Treatment Market Share by Region (2016-2027) Figure 32. China Smith-Magenis Syndrome Treatment Market Size (2016-2027) & (US$ Million) Figure 33. Japan Smith-Magenis Syndrome Treatment Market Size (2016-2027) & (US$ Million) Figure 34. South Korea Smith-Magenis Syndrome Treatment Market Size (2016-2027) & (US$ Million) Figure 35. Southeast Asia Smith-Magenis Syndrome Treatment Market Size (2016-2027) & (US$ Million) Figure 36. India Smith-Magenis Syndrome Treatment Market Size (2016-2027) & (US$ Million) Figure 37. Australia Smith-Magenis Syndrome Treatment Market Size (2016-2027) & (US$ Million) Figure 38. Rest of Asia-Pacific Smith-Magenis Syndrome Treatment Market Size (2016-2027) & (US$ Million) Figure 39. Latin America Smith-Magenis Syndrome Treatment Market Share by Country (2016-2027) Figure 40. Mexico Smith-Magenis Syndrome Treatment Market Size (2016-2027) & (US$ Million) Figure 41. Brazil Smith-Magenis Syndrome Treatment Market Size (2016-2027) & (US$ Million) Figure 42. Rest of Latin America Smith-Magenis Syndrome Treatment Market Size (2016-2027) & (US$ Million) Figure 43. Middle East & Africa Smith-Magenis Syndrome Treatment Market Share by Country (2016-2027) Figure 44. Turkey Smith-Magenis Syndrome Treatment Market Size (2016-2027) & (US$ Million) Figure 45. Saudi Arabia Smith-Magenis Syndrome Treatment Market Size (2016-2027) & (US$ Million) Figure 46. UAE Smith-Magenis Syndrome Treatment Market Size (2016-2027) & (US$ Million) Figure 47. Rest of Middle East & Africa Smith-Magenis Syndrome Treatment Market Size (2016-2027) & (US$ Million) Figure 48. Bottom-up and Top-down Approaches for This Report Figure 49. Data Triangulation

Rhythm Pharmaceuticals Vanda Pharmaceuticals Neurim Pharmaceuticals Novartis Takeda Pharmaceutical Sanofi Johnson & Johnson Eisai Teva Pharmaceutical Industries Boehringer Ingelheim International ALLERGAN Roche Holding Purdue Pharma PhotoPharmics